insights_auto
Why is GMAB up 3.78%?
Dive Deeperchevron_right
GMAB:CPH
Genmab A/S
DKK 2,445.00
arrow_upward
+3.78%(+89.00) 1D
Oct 9, 5:00:00 PM GMT+2 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
DKK 2,425.00
High
DKK 2,472.00
Low
DKK 2,400.00
Mkt. cap
146.84B
Avg. vol.
125.50K
Volume
96.37K
52-wk high
DKK 2,603.00
52-wk low
DKK 1,512.00
Shares outstanding
62.41M
No. of employees
3K
Open
DKK 2,425.00
High
DKK 2,472.00
Low
DKK 2,400.00
Mkt. cap
146.84B
Avg. vol.
125.50K
Volume
96.37K
52-wk high
DKK 2,603.00
52-wk low
DKK 1,512.00
Shares outstanding
62.41M
No. of employees
3K
News stories
From web sources and news partners
Investing.com
·
2 days ago
H.C. Wainwright raises Genmab stock price target on positive trial data
TradingView
·
2 days ago
Genmab A/S Stock 12‑Month Price Target Raised to $42, Implies 9% Upside
Yahoo Finance
·
3 days ago
Dual-acting drug from AbbVie, Genmab scores in frontline lymphoma trial
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab A/S
CEOJan G. J. van de Winkel
Employees3.12K
FoundedJun 11, 1998
Headquarters-
SectorBiotechnology
Websitegenmab.com